Patents by Inventor Udo Oppermann

Udo Oppermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGONUCLEOTIDES
    Publication number: 20240102091
    Abstract: The invention relates to methods of adding identifier sequences to polynucleotides of an array. The identifier sequences comprise a plurality of nucleotide blocks. Also provided are arrays of polynucleotides having identifier sequences, microparticles comprising said arrays, a plurality of 5 said microparticles, surfaces comprising said arrays, kits and methods for generating libraries using the array, methods for determining the accuracy of sequencing or amplification an array, and methods of analysing said libraries.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 28, 2024
    Inventors: Martin PHILPOTT, Adam CRIBBS, Udo OPPERMANN, Tom BROWN, Jr., Tom BROWN, Sr., Jonathan Francis WATSON
  • POLYNUCLEOTIDE ARRAYS
    Publication number: 20230183794
    Abstract: The invention relates to micro-particles in which polynucleotides are joined to a bead at the 3? end and include a linker that can be cleaved to separate the polynucleotides from the bead and provide free 3? hydroxyl groups. Also provided are arrays of polynucleotides, pluralities of micro-particles, fluidic compartments comprising micro-particles, methods of synthesising the arrays and methods of generating libraries using the array.
    Type: Application
    Filed: May 13, 2021
    Publication date: June 15, 2023
    Inventors: Adam CRIBBS, Martin PHILPOTT, Udo OPPERMANN, Tom BROWN, JR., Tom BROWN, Jonathan Francis WATSON
  • INHIBITORS AND ANTAGONISTS OF GPR84 FOR THE TREATMENT OF ENDOMETRIOSIS
    Publication number: 20210401823
    Abstract: The present invention relates to an antagonist or inhibitor of G protein-coupled receptor 84 (GPR84) for use in the treatment and/or prevention of a patient suffering from, at risk of developing, and/or being diagnosed for endometriosis, as well as methods of screening for such antagonist or inhibitor as well as methods for diagnosis.
    Type: Application
    Filed: May 15, 2018
    Publication date: December 30, 2021
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Frank SACHER, Maik OBENDORF, Gernot LANGER, Fernando MARTINEZ ESTRADA, Udo OPPERMANN, Catherine SHANG
  • Methods for protein purification
    Publication number: 20050186659
    Abstract: The present invention relates to process for the production of a soluble polypeptide having at least one ligand binding site, the process comprising (i) providing a host cell comprising a nucleic acid sequence encoding the soluble polypeptide; (ii) culturing the host cell under conditions whereby the polypeptide is produced, wherein the cell culture medium comprises a non-proteinaceous ligand capable of binding to a ligand binding site of the polypeptide; and (iii) recovering said polypeptide.
    Type: Application
    Filed: January 20, 2005
    Publication date: August 25, 2005
    Inventors: Lars Abrahmsen, Joakim Nilsson, Udo Oppermann, Stefan Svensson